Immunohistochemical localization of the cloned κ1 receptor in the rat CNS and pituitary

Neuroscience

Volumn 71, Issue 3, 1996, Pages 671-690

  Mansour, A ^a   Burke, S ^a   Pavlic, R J ^a   Akil, H ^a   Watson, S J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Dynorphin; Endorphin receptor; Endorphins; Mesolimbic dopamine; Nociception; Pain

Indexed keywords

KAPPA OPIATE RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD;

EID: 0030049833     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-4522(95)00464-5     Document Type: Article

References (68)

1. Arvidsson U., Dado R. J., Riedl M., Lee J.-H., Law P. Y., Loh H. H., Eide R. and Wessendorf M. W. (1995) δ-Opioid receptor immunoreactivity: distribution in brainstem and spinal cord, and relationship to biogenic amines and enkephalin. J. Neurosci. 15, 1215-1235.
2. Arvidsson U., Riedl M., Chakrabarti S., Lee J.-H., Nakano A. H., Dado R. J., Loh H. H., Law P. Y., Wessendorf M. W. and Elde R. (1995) Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 15, 3328-3341.
3. Besse D., Lombard M. C., Zajac J. M., Roques B. P. and Besson J. M. (1990) Pre-and postsynaptic distribution of μ, δ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res. 521, 15-22.
4. Boersma C. J. C. and Van Leeuwen F. W. (1994) Technical aspects of opioid receptor localization: detection of opioid receptor proteins by immunocytochemistry or with a biotinylated dynorphin analog. J. Neurosci. Meth. 51, 217-227.
5. Boersma C. J. C., Van Heerikhuize J. J., Pool C. W. and Van Leeuwen F. W. (1993) Characterization of opioid binding sites in the rat pituitary gland by quantitative receptor autoradiography. J. Neuroendocr. 6, 47-56.
6. Carter D. A. and Lightman S. L. (1985) Selective cardiovascular and neuroendocrine effects of a κ-opioid agonist in the nucleus tractus solitarii of rats. J. Physiol. 367, 363-375.
7. Chen C. A. and Okayama H. (1987) High efficiency transformation of mammalian cells by plasmid DNA. Molec. Cell Biol. 7, 2745-2752.
8. Cupo A., Conrath M., Eybalin M., Fourrier O., Zauoui D., Kaldy P. and Herbrecht F. (1992) Monoclonal antiidiotypic antibodies against delta opioid receptors as an electron microscopy probe. Eur. J. Cell Biol. 57, 273-284.
9. Di Chiara G. and Imperato A. (1988) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmac. exp. They. 244, 1067-1080.
10. Douglas A. J., Dye S., Leng G., Russell J. A. and Bicknell R. J. (1993) Endogenous opioid regulation of oxytocin secretion through pregnancy in the rat. J. Neuroendocr. 5, 307-314.
11. Fox D. A. and Burks T. F. (1988) Roles of central and peripheral mu, delta and kappa opioid receptors in the mediation of gastric acid secretory effects in the rat. J. Pharmac. exp. Ther. 244, 456-462.
12. Fukada K., Kato S., Mori K., Nishi M. and Takeshima H. (1993) Primary structures and expression from cDNAs of rat opioid receptor δ-and μ-subtypes. Fedn Eur. biochem. Socs Lett. 327, 311-314.
13. Gillan M. G. C. and Kosterlitz H. W. (1982) Spectrum of the μ-, δ-and κ-binding sites in homogenates of rat brain. Br. J. Pharmac. 77, 461-469.
14. Goldstein A. and Naidu A. (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Molec. Pharmac. 36, 265-272.
15. Gramsch C., Schultz R., Kosin S. and Herz A. (1988) Monoclonal anti-idiotypic antibodies to opioid receptors. J. biol. Chem. 263, 5853-5859.
16. Guan K. and Dixon J. E. (1991) Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Analyt. Biochem. 192, 262-267.
17. Hamon G. and Jouquey S. (1990) Kappa agonists and vasopressin secretion. Horm. Res. 34, 129-132.
18. Hayes A. G. and Stewart B. R. (1985) Effect of μ and κ opioid receptor agonists on rat plasma corticosterone levels. Eur. J. Pharmac. 166, 75-79.
19. Heidbreder C. A. and Shippenberg T. S. (1994) U-69593 prevents cocaine sensitization by normalizing basal accumbens dopamine. NeuroReport 5, 1797-1800.
20. Herkenham M., Rice K. C., Jacobson A. E. and Rothman R. B. (1986) Opiate receptors in rat pituitary are confined to the neural lobe and are exclusively kappa. Brain Res. 382, 365-371.
21. Iwamoto E. T. (1986) Place-conditioning properties of mu, kappa, and sigma opiod agonists. Alcohol Drug Res. 6, 327-339.
22. Iyengar S., Kim H. S. and Wood P. L. (1986) Effect of kappa opiate agonists on neurochemical and neuroendocrine indices: evidence for kappa receptor subtypes. Life Sci. 39, 637-644.
23. Iyengar S., Kim H. S. and Wood P. L. (1986) Kappa opiate agonists modulate the hypothalamic pituitary-adrenocortical axis in the rat. J. Pharmac. exp. Ther. 238, 429-436.
24. Iyengar S., Kim H. S. and Wood P. L. (1987) μ, δ-and ∈-opioid receptor modulation of the hypothalamic-pituitary-adrenocortical (HPA) axis: subchronic tolerance studies of endogenous opioid peptides. Brain Res. 435, 220-226.
25. Janik J., Klosterman S., Parman R. and Callahan P. (1994) Multiple opiate receptor subtypes are involved in the stimulation of growth hormone release by beta-endorphin in female rats. Neuroendocrinology 60, 69-75.
26. Jomary C., Gairin J. E. and Beaudet A. (1992) Synaptic localization of κ opioid receptors in guinea pig neostriatum. Proc. natn. Acad. Sci. U.S.A. 89, 564-568.
27. 2+ in secretory nerve terminals of the neurohypophysis. Brain Res. 574, 138-146.
28. Krulich L., Koenig J. I., Conway S., McCann S. M. and Mayfield M. A. (1986) Opioid κ receptors and the secretion of prolactin (PRL) and growth hormone (GH) in the rat. Neuroendocrinology 42, 75-81.
29. Kusomoto K., Mackay K. B. and McCulloch J. (1992) The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia. Brain Res. 576, 147-151.
30. Lai J., Ma S.-W., Zhu R.-H., Rothman R. B., Lentes K.-U. and Porreca F. (1994) Pharmacological characterization of the cloned kappa opioid receptor as a kappa1b subtype. NeuroReport 5, 2161-2164.
31. Leadem C. A. and Yagenova S. V. (1987) Effects of specific activation of mu-, delta-and kappa-opioid receptors on the secretion of luteinizing hormone and prolactin in the ovariectomized rat. Neuroendocrinology 45, 109-117.
32. Leander J. D., Hart J. C. and Zerbe R. L. (1987) Kappa agonist-induced diuresis: evidence for stereoselectivity, strain differences, independence of hydration variable and a result of decreased plasma vasopressin levels. J. Pharmac. exp. Ther. 242, 33-39.
33. Maderspach K. and Németh K. (1993) Immunocytochemical visualization of kappa-opioid receptors on chick embryonic neurons differentiating in vitro. Neuroscience 57, 459-465.
34. Maderspach K., Németh K., Simon J., Benyhe S., Szücs M. and Wollemann, M. (1991) A monoclonal antibody recognizing κ-but not μ-and δ-opioid receptors. J. Neurochem. 56, 1897-1904.
35. Mansour A. and Watson S. J. (1993) Anatomical distribution of opioid receptors in mammalians: an overview. In Handbook of Experimental Pharmacology (ed. Herz A.), Vol. 104, pp. 79-105. Springer, Berlin.
36. Mansour A., Fox C. A., Akil H. and Watson S. J. (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18, 22-29.
37. Mansour A., Fox C. A., Burke S., Akil H. and Watson S. J. (1995) Immunohistochemical localization of the cloned μ opioid receptor in the rat CNS. J. Chem. Neuroanat. 8, 283-305.
38. Mansour A., Fox C. A., Burke S., Meng F., Thompson R. C., Akil H. and Watson S. J. (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. comp. Neurol. 350, 412-438.
39. 1 Receptor mRNA distribution in the rat CNS: comparison to κ receptor binding and prodynorphin mRNA. Molec. Cell. Neurosci. 5, 124-144.
40. Mansour A., Hoversten M. T., Taylor L. P., Watson S. J. and Akil H. (1995) The cloned μ, δ and κ receptors and their endogeneous ligands: evidence for two opioid peptide recognition cores. Brain Res. Submitted.
41. Mansour A., Khachaturian H., Lewis M. E., Akil H. and Watson S. J. (1988) Anatomy of CNS opioid receptors. Trends Neurosci. 11, 308-314.
42. Mansour A., Khachaturian H., Lewis M. E., Akil H. and Watson S. J. (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7, 2445-2464.
43. Manzanares J., Lookingland K. J. and Moore K. E. (1990) Kappa-opioid-receptor-mediated regulation of α-melanocyte-stimulating hormone secretion and tuberohypophysial dopaminergic neuronal activity. Neuroendocrinology 52, 200-205.
44. Manzanares J., Lookingland K. J. and Moore K. E. (1991) Kappa opioid receptor-mediated regulation of dopaminergic neurons in the rat brain. J. Pharmac. exp. Ther. 256, 500-505.
45. Manzanares J., Lookingland K. J., La Vigne S. D. and Moore K. E. (1991) Activation of tuberohypophysial dopamine neurons following intracerebroventricular administration of the selective kappa opioid receptor antagonist norbinaltorphimine. Life Sci. 48, 1143-1149.
46. Martin W. R., Eades C. G., Thompson J. A., Huppler R. E. and Gilbert P. E. (1976) The effects of morphine-and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmac. exp. Ther. 197, 517-532.
47. Meng F., Xie G.-X., Thompson R. C., Mansour A., Goldstein A., Watson S. J. and Akil H. (1993) Cloning and pharmacological characterization of a rat κ opioid receptor. Proc. natn. Acad. Sci. U.S.A. 90, 9954-9958.
48. Millan M. J. (1990) κ-Opioid receptors and analgesia. Trends pharmac. Sci. 11, 70-76.
49. Minami M., Hosoi Y., Toya T., Katao Y., Maekawa K., Katsumata S., Yabuuchi K., Onogi T. and Satoh M. (1993) In situ hybridization study of κ-opioid receptor mRNA in the rat brain. Neurosci. Lett. 162, 161-164.
50. Mucha R. F. and Herz A. (1985) Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86, 274-280.
51. Nock B., Giordano A. L., Cicero T. J. and O'Connor L. H. (1990) Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor. J. Pharmac. exp. Ther. 254, 412-419.
52. 3H]ethylketocyclazocine. Life Sci. 42, 2403-2412.
53. Porreca F., Mosberg H. I., Hurst R., Hruby V. J. and Burks T. F. (1984) Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J. Pharmac. exp. Ther. 230, 341-348.
54. Rimoy G. H., Wright D. M., Bhaskar N. K. and Rubin P. C. (1994) The cardiovascular and central nervous system effects in the human of U-62066E. Eur. J. clin. Pharmac. 46, 203-207.
55. Ronken E., Van Muiswinkel F. L., Mulder A. H. and Schoffelmeer A. N. M. (1993) Opioid receptor-mediated inhibition of evoked catecholamine release from cultured neurons of rat ventral mesencephalon and locus coeruleus. Eur. J. Pharmac. 230, 349-355.
56. Schmidt P., Schröeder H., Maderspach K. and Staak M. (1994) Immunohistochemical localization of κ opioid receptors in the human frontal cortex. Brain Res. 654, 223-233.
57. Sharif N. A. and Hughes J. (1989) Discrete mapping of brain mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors. Peptides 10, 499-522.
58. Singh L., Vass C. A., Hunter J. C., Woodruff G. N. and Hughes J. (1990) The anticonvulsant action of CI-977, a selective κ-opioid receptor agonist: a possible involvement of the glycine/NMDA receptor complex. Eur. J. Pharmac. 191, 477-480.
59. Smith D. B. and Johnson K. S. (1988) Single-step purification of polypeptides expressed in Eschericha coli as fusions with glutathione S-transferase. Gene 67, 31-40.
60. Spanagel R., Herz A. and Shippenberg T. S. (1990) The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study. J. Neurochem. 55, 1734-1740.
61. Spanagel R., Herz A. and Shippenberg T. S. (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. natn. Acad. Sci. U.S.A. 89, 2046-2050.
62. Thompson R. C., Mansour A., Akil H. and Watson S. J. (1993) Cloning and pharmacological characterization of a rat n opioid receptor. Neuron 11, 903-913.
63. Tiberi M. and Magnan J. (1990) Quantitative analysis of multiple κ-opioid receptors by selective and nonselective ligand binding in guinea pig spinal cord: resolution of high and low affinity states of the κ2 receptors by a computerized model-fitting technique. Molec. Pharmac. 37, 694-703.
64. Watson S. J., Khachaturian H., Akil H., Coy D. H. and Goldstein A. (1982) Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science 218, 1134-1136.
65. Wollemann M., Benyhe S. and Simon J. (1993) The kappa-opioid receptor: evidence for the different subtypes. Life Sci. 52, 599-611.
66. Wood P. L. (1982) Multiple opiate receptors: support for unique mu, delta and kappa sites. Neuropharmacology 21, 487-497.
67. Zhao B.-G., Chapman C. and Bicknell R. J. (1988) Functional κ-opioid receptors on oxytocin and vasopressin nerve terminals isolated from the rat neurohypophysis. Brain Res. 462, 62-66.
68. 2 receptors. Proc. natn. Acad. Sci. U.S.A. 85, 4061-1065.